Log in to save to my catalogue

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial...

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5b2df9b236c45ad9646847f11573838

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial Study

About this item

Full title

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial Study

Publisher

Tehran: Royan Institute of Iran

Journal title

International journal of fertility & sterility, 2022-10, Vol.16 (4), p.251-255

Language

English

Formats

Publication information

Publisher

Tehran: Royan Institute of Iran

More information

Scope and Contents

Contents

Background: Growth hormone (GH) is a potential treatment in the assisted reproductive technology (ART) to improve endometrial receptivity and thickness. In the current study, we investigated the effect of the intrauterine administration of GH on the endometrial thickness (EMT) and ART outcomes in the patients with refractory thin endometrium. Mater...

Alternative Titles

Full title

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b5b2df9b236c45ad9646847f11573838

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5b2df9b236c45ad9646847f11573838

Other Identifiers

ISSN

2008-076X

E-ISSN

2008-0778

DOI

10.22074/ijfs.2022.541389.1210

How to access this item